Financial Performance - Total operating revenue for Q1 2024 was RMB 4,949,345,961.54, a decrease of 23.59% compared to RMB 6,477,062,887.66 in the same period last year[3] - Net profit attributable to shareholders was RMB 1,538,328,759.88, down 28.67% from RMB 2,156,742,527.33 year-on-year[3] - Basic earnings per share decreased to RMB 0.17, a decline of 37.04% from RMB 0.27 in the previous year[3] - Total profit for the current period is ¥1,821,164,608.65, down from ¥2,838,034,953.16 in the previous period, a decrease of about 35.8%[19] - Total comprehensive income for the current period is ¥2,418,682,376.86, slightly down from ¥2,472,473,228.32 in the previous period, a decrease of approximately 2.2%[19] Cash Flow - The net cash flow from operating activities was RMB -11,861,776,432.59, indicating a significant outflow compared to RMB -4,582,031,552.90 in the same period last year[7] - Total cash inflow from operating activities is ¥84,621,439,959.76, compared to ¥47,907,559,435.46 in the previous period, showing an increase of about 76.7%[21] - Cash outflow from operating activities totals ¥96,483,216,392.35, up from ¥52,489,590,988.36 in the previous period, indicating an increase of approximately 83.8%[21] - The net cash flow from financing activities was approximately ¥8.29 billion, a significant improvement from a negative cash flow of ¥625.92 million in the prior period[22] - The company reported a net increase in cash and cash equivalents of approximately ¥5.06 billion, recovering from a decrease of ¥2.09 billion in the prior period[22] Assets and Liabilities - Total assets increased to RMB 759,773,963,785.73, up 11.37% from RMB 682,181,679,228.41 at the end of the previous year[3] - The company's total liabilities increased to 614.68 billion yuan from 541.51 billion yuan at the beginning of the year[16] - The total equity attributable to the owners of the parent company was 139.96 billion yuan, up from 135.72 billion yuan at the beginning of the year[17] - The company reported cash and cash equivalents of approximately 128.90 billion yuan at the end of the reporting period, compared to 118.82 billion yuan at the beginning of the year[14] Investments - The company reported a 39.61% increase in trading financial assets, reaching RMB 301,658,081,615.40, due to an increase in fixed income investments[6] - The company’s investment income decreased by 50.09% to RMB 750,966,943.33, attributed to reduced gains from trading financial instruments[6] - The net increase in cash from investment activities is ¥860,790,484.80, compared to ¥3,302,689,070.77 in the previous period, indicating a significant decrease[21] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 219,009, with 217,563 being A-share shareholders and 1,446 H-share shareholders[8] - The top 10 shareholders hold a combined 88.67% of the total shares, with Hong Kong Central Clearing (Agent) Limited holding 22.31% (1,700,128,840 shares) and Jilin Aodong Pharmaceutical Group Co., Ltd. holding 16.44% (1,252,768,767 shares)[10] - The company completed the acquisition of 366,000,000 shares of Wisdom Group, representing approximately 20.04% of its total issued shares[12] - The largest shareholder, Jilin Aodong, increased its stake by acquiring 2,086,600 H-shares, bringing its total holdings to 1,526,304,167 shares, or 20.0274% of the total share capital[12] Strategic Initiatives - The company announced a "Quality Return Dual Improvement" action plan aimed at enhancing investor confidence and promoting sustainable development[12] - The company aims to strengthen core competitiveness and improve governance as part of its strategic initiatives[12] Other Information - The first quarter report remains unaudited, indicating a need for further verification of the financial data presented[22] - No preferred shareholders were reported for the company, indicating a focus on ordinary shares[11]
广发证券(01776) - 2024 Q1 - 季度业绩